Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.

PloS one - 1 Jan 2020

Al-Salam Suhail, Sharma Charu, Afandi Bachar, Al Dahmani Khaled, Al-Zahrani Ali S, Al Shamsi Amal, Al Kaabi Juma

Abstract excerpt

BACKGROUND: Papillary thyroid carcinoma (PTC) is the most common malignant thyroid neoplasm comprising 80-90% of all thyroid malignancies. Molecular changes in thyroid follicular cells are likely associated with the development of PTC. Mutations in serine/threonine-protein kinase (BRAF) and Rat sarcoma viral oncogene homolog (RAS) are commonly seen in PTC. METHODS: In total, 90 cases of PTC are randomly selected...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Mass Index
Share to Lymphatic Metastasis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to United Arab Emirates

Source

Open in PubMed Open full text

Identifiers

PMID: 32315324
DOI: 10.1371/journal.pone.0231341
PMCID: PMC7173769

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.PMID 32315324Read ↗

BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.Semantic proximity Read ↗

BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications.Semantic proximity Read ↗

Targeting of the BRAF gene in papillary thyroid carcinoma (review).Semantic proximity Read ↗

Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case seriesSemantic proximity Read ↗

The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review.Semantic proximity Read ↗

Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.Semantic proximity Read ↗

BRAF V600E Mutations in Papillary Thyroid Carcinoma: Their Relation to Clinical Features and Oncologic Outcomes in A Single Cancer Centre ExperienceSemantic proximity Read ↗

Comparative BRAF V600E immunohistochemical expression in differentiated thyroid tumors with papillary features.Semantic proximity Read ↗

The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations.Semantic proximity Read ↗

Surgical perspective of T1799A BRAF mutation diagnostic value in papillary thyroid carcinoma.Semantic proximity Read ↗

BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review).Semantic proximity Read ↗

Roles of RAS and BRAF mutations in thyroid carcinogenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.